Five Queen’s research programs will receive $250,000 each, including four collaborative projects featuring QHS researchers:
The genetic and epigenetic origins of cancer are the root of a program led by Anna Panchenko (Pathology and Molecular Medicine) and Maria Aristizabal (Biology). The team will investigate the role of mutations in histone genes in the genesis of cancer using an integrative in silicon in vivo platform. Histones are proteins that help form the structure of chromosomes and might have the potential to be used as diagnostic biomarkers or targets for therapeutic intervention.
Cutting-edge health sciences projects played a starring role in attracting $3M in new research funding to Queen’s.
Queen’s Health Sciences researchers are responsible for over half of the university’s projects selected as part of the Government of Canada’s investment to support high-risk, high-reward research through the New Frontiers in Research Fund (NFRF) Exploration and Research in a Pandemic Context streams.